Correlation Between Pliant Therapeutics and Marker Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Marker Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Marker Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Marker Therapeutics, you can compare the effects of market volatilities on Pliant Therapeutics and Marker Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Marker Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Marker Therapeutics.
Diversification Opportunities for Pliant Therapeutics and Marker Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pliant and Marker is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Marker Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marker Therapeutics and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Marker Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marker Therapeutics has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Marker Therapeutics go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Marker Therapeutics
Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 0.45 times more return on investment than Marker Therapeutics. However, Pliant Therapeutics is 2.23 times less risky than Marker Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Marker Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 1,407 in Pliant Therapeutics on September 1, 2024 and sell it today you would lose (27.00) from holding Pliant Therapeutics or give up 1.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Marker Therapeutics
Performance |
| Timeline |
| Pliant Therapeutics |
| Marker Therapeutics |
Pliant Therapeutics and Marker Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Marker Therapeutics
The main advantage of trading using opposite Pliant Therapeutics and Marker Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Marker Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will offset losses from the drop in Marker Therapeutics' long position.| Pliant Therapeutics vs. Tff Pharmaceuticals | Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. Inhibrx | Pliant Therapeutics vs. Enliven Therapeutics |
| Marker Therapeutics vs. Lumos Pharma | Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |